301 related articles for article (PubMed ID: 25476248)
41. Asthma-derived fibroblast to myofibroblast transition is enhanced in comparison to fibroblasts derived from non-asthmatic patients in 3D in vitro culture due to Smad2/3 signalling.
Wnuk D; Lasota S; Paw M; Madeja Z; Michalik M
Acta Biochim Pol; 2020 Nov; 67(4):441-448. PubMed ID: 33245228
[TBL] [Abstract][Full Text] [Related]
42. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
43. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
44. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF.
Pechkovsky DV; Prêle CM; Wong J; Hogaboam CM; McAnulty RJ; Laurent GJ; Zhang SS; Selman M; Mutsaers SE; Knight DA
Am J Pathol; 2012 Apr; 180(4):1398-412. PubMed ID: 22322297
[TBL] [Abstract][Full Text] [Related]
45. Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts.
Prasad C; Hahn K; Duraisamy SK; Salathe MA; Huang SK; Burris TP; Sundar IK
Biochem Biophys Res Commun; 2023 Aug; 669():120-127. PubMed ID: 37269594
[TBL] [Abstract][Full Text] [Related]
46. Lysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation.
Huang LS; Jiang P; Feghali-Bostwick C; Reddy SP; Garcia JGN; Natarajan V
Free Radic Biol Med; 2017 Nov; 112():162-173. PubMed ID: 28751023
[TBL] [Abstract][Full Text] [Related]
47. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
Freise C; Querfeld U
Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
[TBL] [Abstract][Full Text] [Related]
49. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
50. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
Bocchino M; Agnese S; Fagone E; Svegliati S; Grieco D; Vancheri C; Gabrielli A; Sanduzzi A; Avvedimento EV
PLoS One; 2010 Nov; 5(11):e14003. PubMed ID: 21103368
[TBL] [Abstract][Full Text] [Related]
51. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
[TBL] [Abstract][Full Text] [Related]
52. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
53. Hypoxia and transforming growth factor β1 regulation of long non-coding RNA transcriptomes in human pulmonary fibroblasts.
Senavirathna LK; Huang C; Pushparaj S; Xu D; Liu L
Physiol Rep; 2020 Jan; 8(1):e14343. PubMed ID: 31925944
[TBL] [Abstract][Full Text] [Related]
54. PDGF-Ralpha gene expression predicts proliferation, but PDGF-A suppresses transdifferentiation of neonatal mouse lung myofibroblasts.
Kimani PW; Holmes AJ; Grossmann RE; McGowan SE
Respir Res; 2009 Nov; 10(1):119. PubMed ID: 19939260
[TBL] [Abstract][Full Text] [Related]
55. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
[TBL] [Abstract][Full Text] [Related]
56. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
[TBL] [Abstract][Full Text] [Related]
57. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
58. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
[TBL] [Abstract][Full Text] [Related]
59. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis.
Artaud-Macari E; Goven D; Brayer S; Hamimi A; Besnard V; Marchal-Somme J; Ali ZE; Crestani B; Kerdine-Römer S; Boutten A; Bonay M
Antioxid Redox Signal; 2013 Jan; 18(1):66-79. PubMed ID: 22703534
[TBL] [Abstract][Full Text] [Related]
60. Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung.
Sava P; Ramanathan A; Dobronyi A; Peng X; Sun H; Ledesma-Mendoza A; Herzog EL; Gonzalez AL
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]